Noncash Share-based Compensation Noncash Share-based Compensation Share Based Compensation - Stock Option Rollforward (Details) (USD $) | 12 Months Ended | |
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 |
Employee Stock Option [Member] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 1,160,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | -196,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | 0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | 3,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 961,377 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | 961,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $11.12 | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $0 | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $7.37 | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $14.93 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $11.87 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $11.87 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 2 years 9 months 18 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term | 2 years 9 months 18 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $15,006 | [1] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | 15,006 | [1] | | | |
Restricted Stock Units (RSUs) [Member] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 1,028,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 1,864,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 4 years 7 months 25 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | 51,231 | [2] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 1,543,000 | | | | 1,830,291 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | -582,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | -125,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 1,822,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $18.25 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $33.46 | | $20.08 | $18.65 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $17.42 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $25.28 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $26.67 | | $18.25 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $26.60 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 4 years 7 months 21 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | 50,067 | [2] | | | |
Stock Appreciation Rights (SARs) [Member] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | -48,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | 0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | 0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 673,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | 662,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $10.74 | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $0 | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $10.59 | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $10.75 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 5 years 9 months 26 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term | 5 years 9 months 22 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | 11,260 | [3] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 721,000 | | | | 673,068 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 673,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 5 years 9 months 26 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | 11,260 | [3] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $11,083 | [3] | | | |
Market Share Units (MSUs) [Member] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 469,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 198,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 205,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | -18,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | 0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired In Period, Weighted Average Grant Date Fair Value | $0 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 444,000 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 469,000 | | | | 444,272 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $34.24 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $48.54 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $26.08 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $43.07 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $44.03 | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms | 6 years 3 months 18 days | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value | $12,209,000 | [4] | | | |
|
[1] | The aggregate intrinsic value was calculated based on the positive difference between the estimated fair value of the Companybs common stock on DecemberB 31, 2014 of $27.48 and the grant date fair value. |
[2] | The aggregate intrinsic value was calculated based on the fair value of the Companybs common stock on DecemberB 31, 2014 of $27.48. |
[3] | StockB appreciationrightsB WeightedB averageexercise priceB WeightedB averageremainingB contractualterm (year)B AggregateintrinsicB valueB (1)Outstanding, December 31, 2013721B $10.74 GrantedbB b Exercised(48)B 10.59 ForfeitedbB b ExpiredbB b Outstanding, December 31, 2014673B $10.75B 5.82B $11,260Exercisable at December 31, 2014662B $10.74B 5.81B $11,083Vested and expected to vest at December 31, 2014673B $10.75B 5.82B $11,260(1) The aggregate intrinsic value was calculated based on the positive difference between the estimated fair value of the Companybs common stock on DecemberB 31, 2014 of $27.48 and the exercise price of the underlying SARs. |
[4] | The aggregate intrinsic value was calculated based on the positive difference between the estimated fair value of the Companybs common stock on DecemberB 31, 2014 of $27.48 and the grant date fair value of the underlying MSUs. |